What CapVest does

CapVest is a London-headquartered private equity firm founded in 1999 that invests as a principal in controlling stakes of mid-to-large-sized companies operating in non-discretionary end markets — primarily consumer staples, healthcare, and essential services. The firm maintains a deliberately concentrated portfolio (sources list roughly a dozen active platforms) and supports portfolio company management with patient capital for both organic growth and acquisition-led consolidation, positioning itself as a sector consolidator rather than a financial-engineering buyer.

CapVest's revenue model is standard for a mid-to-large-cap buyout firm: it raises capital from institutional Limited Partners into closed-end funds (referenced as "Fund III" in firmographic data) and earns a combination of management fees on committed/invested capital and carried interest on realizations. The firm does not sell products or services to end customers; instead, its customers are institutional LPs (pension funds, endowments, family offices) who commit capital to successive vehicles. CapVest's operating footprint spans London (headquarters), New York, and Dublin, with portfolio company operations covering Europe (UK, Germany, France, Nordics, Benelux, Central Europe) and North America.

The platform has executed multiple large transactions over 2025–2026, including the €10 billion STADA Arzneimittel AG buyout in March 2026, a $7 billion continuation-vehicle recapitalization of Curium in November 2025, the announced €1.8 billion acquisition of TSG in February 2026, and the $500 million commitment to expand Datasite including its acquisition of Blueflame AI. Other notable holdings include Natra (chocolate, acquired from Investindustrial at ~€500 million), Inspired Pet Nutrition, Performance Fluids Experts Group/Recochem, NextPharma, Klipboard/Kerridge Commercial Systems, Rodericks Dental Partners, and Second Nature Brands. The portfolio strategy emphasizes resilient, non-cyclical demand drivers, with bolt-on activity within platforms (e.g., Natra's acquisition of Gudrun, Inspired Pet Nutrition's pursuit of Ultra Premium Direct and Sopral) supporting a build-and-consolidate thesis.

Name

CapVest

Legal name

CapVest Partners LLP

Website

http://www.capvest.co.uk/home/

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

51–100 employees

Short description

CapVest is a London-based private equity firm founded in 1999 that acquires controlling stakes in mid-to-large companies across consumer staples, healthcare, and essential services, supporting management teams with patient capital for organic and acquisition-led growth.

Ownership category

akta.pro rank

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Distribution channels1 record

Marketing channels2 records

Core offering

CapVest is a private equity investment firm that acquires controlling stakes in companies operating in highly resilient industries with non-discretionary demand, including consumer staples, healthcare, and essential services. The firm partners with management teams to transform portfolio company size and scale through both organic growth initiatives and acquisition-led strategies, deploying patient capital with a long-term horizon.

Product overview

CapVest is a private equity investment firm that does not offer a unified product or platform in the traditional SaaS sense. Rather than operating a product business, CapVest acquires and manages controlling stakes in portfolio companies across healthcare, consumer staples, and essential services sectors. The firm focuses on transforming the size and scale of portfolio companies through both organic growth and acquisition-led strategies. CapVest is not a product company and therefore has no products or services in its own portfolio to describe.

Differentiator

Problem solved

Functional benefit

Products and services

• Private Equity Fund Management CapVest raises capital from institutional investors including pension funds, endowments, and family offices through private equity fund vehicles, and deploys that capital to acquire controlling stakes in companies in resilient industries.
• Portfolio Company Transformation Services CapVest partners with management teams of portfolio companies to transform their size and scale through organic growth initiatives and acquisition-led strategies, providing active and engaged dialogue, fast decision-making, and additional capital deployment.

Quantifiable outcome

• STADA achieved record revenues of €4.3 billion and adjusted EBITDA of €961 million in 2025 under CapVest's ownership
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• STADA Arzneimittel AGcoreStrategic or Co-development Partner · 31 March 2026CapVest completed acquisition of a majority stake in STADA, a global healthcare and pharmaceuticals company. STADA reported record revenues of €4.3 billion and adjusted EBITDA of €961 million in 2025, with nearly 12,000 employees worldwide.
• DatasitecoreStrategic or Co-development Partner · 11 August 2025CapVest Partners committed $500 million toward expanding Datasite's intelligence solutions organically and inorganively. This investment enabled Datasite to acquire Blueflame AI, a leading provider of agentic AI solutions for investment and financial services.

Scale indicators14 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• BC Partners: BC Partners is a London-based mid-to-large-cap private equity firm with a similar sector focus on consumer, healthcare, and industrials/services in Europe. Comparable in size, deal cadence, and cross-border European buyout activity to CapVest.
• Charterhouse Capital Partners: UK-headquartered mid-market private equity firm investing in consumer, healthcare, and business services across Europe. Similar in scale, sector tilt, and patient-capital approach to CapVest.
• EQT Partners: Large European-headquartered private equity firm with deep exposure to healthcare (Galderma, Karo Healthcare) and consumer/essential services. Closely comparable business model to CapVest including healthcare platform building.
• Cinven: Pan-European private equity firm focused on healthcare, consumer, and services. Just sold STADA majority to CapVest consortium, evidencing direct peer overlap in mega-cap European healthcare buyouts.
• PAI Partners: European private equity firm investing in mid-to-large-cap consumer, healthcare, and business services. Similar fund size, sector coverage, and patient capital approach as CapVest.
• Sun European Partners: European mid-market private equity firm with a comparable sector focus on consumer and healthcare. Previously sold NextPharma to CapVest, evidencing overlapping deal universe in European pharma services and consumer.
• Ardian: Paris-based private investment house with European mid-to-large-cap buyout activity across consumer, healthcare, and services. Similar fund size, deal cadence, and patient-capital European mid-market positioning as CapVest.

Broad incumbents

• Bain Capital: Global mega-fund private equity platform with broad sector exposure including consumer, healthcare, and services. Co-sold STADA to CapVest, evidencing direct deal-overlap at the large-cap end of CapVest's strategy.
• KKR: Global mega-fund private equity firm with broad healthcare, consumer, and infrastructure exposure. Competes with CapVest for large-cap European deals and is referenced in the same market context.
• Apollo Global Management: Global alternative asset manager raising record sums for energy transition and credit strategies. Cited in the same market context as CapVest and a competitor for large European essential-services and infrastructure deals (e.g., TSG).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/capvest

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A22 records

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CapVest